BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18000229)

  • 1. Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle.
    Kayisli UA; Berkkanoglu M; Kizilay G; Senturk L; Arici A
    Reprod Sci; 2007 Oct; 14(7):678-86. PubMed ID: 18000229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
    Shimomura Y; Matsuo H; Samoto T; Maruo T
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
    Wang J; Ohara N; Takekida S; Xu Q; Maruo T
    Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma.
    Matsuo H; Kurachi O; Shimomura Y; Samoto T; Maruo T
    Oncology; 1999 Oct; 57 Suppl 2():49-58. PubMed ID: 10545803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of PTEN (phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human fibromyomatous uteri.
    Kovács KA; Lengyel F; Vértes Z; Környei JL; Gocze PM; Sumegi B; Szabó I; Vértes M
    J Steroid Biochem Mol Biol; 2007 Feb; 103(2):196-9. PubMed ID: 17097286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
    Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
    Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium.
    Hermon TL; Moore AB; Yu L; Kissling GE; Castora FJ; Dixon D
    Virchows Arch; 2008 Dec; 453(6):557-69. PubMed ID: 18853184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X; Levens E; Williams RS; Chegini N
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
    Zhang ZL; Zhang Y; Xu BQ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells.
    Suzuki K; Nakabayashi K; Yamada AY; Lodhi RS; Hazama R; Ebina Y; Yamada H
    Fertil Steril; 2012 Mar; 97(3):734-41. PubMed ID: 22226177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E; Luo X; Ding L; Williams RS; Chegini N
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development.
    Suzuki A; Kariya M; Matsumura N; Baba T; Yagi H; Mandai M; Konishi I; Fujii S
    Med Mol Morphol; 2012 Dec; 45(4):214-21. PubMed ID: 23224600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
    Wu X; Blanck A; Olovsson M; Henriksen R; Lindblom B
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):77-83. PubMed ID: 11867266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphenol A Concentrates Preferentially in Human Uterine Leiomyoma and Induces Proliferation in Rat Myometrium.
    Othman ER; Al-Adly DM; Elgamal DA; Ghandour N; El-Sharkawy S
    Reprod Sci; 2016 Apr; 23(4):508-14. PubMed ID: 26445998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protein expression of human progesterone receptor isoforms A and B in uterine leiomyoma].
    Tu Z; Wei L; Wang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):740-5. PubMed ID: 11286035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
    Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
    Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells.
    Gao Z; Matsuo H; Wang Y; Nakago S; Maruo T
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5593-9. PubMed ID: 11701740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
    Senturk LM; Sozen I; Gutierrez L; Arici A
    Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.